Haemonetics HAE Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Business | ||||||
| Blood Center | $56.41M-0.3% | $56.56M+0.2% | $56.45M+8.9% | $51.84M-7.4% | $56.01M-20.4% | |
| Hospital | $159.65M+11.3% | $143.5M-1.4% | $145.5M+4.2% | $139.66M-5.5% | $147.86M+2.7% | |
| Plasma | $130.29M-6.2% | $138.91M+10.8% | $125.36M-3.5% | $129.9M+2.5% | $126.74M-5.6% | |
| Total net revenues by Product | ||||||
| Plasma | $130.29M-6.2% | $138.91M+10.8% | $125.36M-3.5% | $129.9M+2.5% | $126.74M-5.6% | |
| Net revenues by Geography | ||||||
| Europe | $52.9M+9.6% | $48.28M+12.4% | $42.97M+5.1% | $40.88M-3.3% | $42.28M-4.3% | |
| Japan | $18.4M+1.5% | $18.14M+0.7% | $18.01M+32.0% | $13.65M-15.3% | $16.11M-0.4% | |
| Other | $3.11M+71.8% | $1.81M-50.8% | $3.68M+31.0% | $2.81M+1.5% | $2.77M-43.9% | |
| Rest of Asia | $19.97M-13.3% | $23.03M+2.0% | $22.57M+4.2% | $21.65M+2.3% | $21.16M-17.3% | |
| United States | $251.97M+1.7% | $247.71M+3.2% | $240.09M-1.0% | $242.4M-2.4% | $248.29M-3.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Haemonetics break its business down?
- Haemonetics (HAE) reports net revenues by business across 3 parts — Blood Center, Hospital and Plasma. Each is extracted from the segment footnotes and tracked over time.
- Where does Haemonetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Haemonetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.